Lumacaftor/ivacaftor changes the lung microbiome and metabolome in cystic fibrosis patients.

Amplicon 16S RNA and metagenomics sequencing revealed that Pseudomonas aeruginosa was most abundant in sputum and seemed to decrease after 6 months of treatment, although this did not reach statistical significance after correction for multiple testing.

also in 111,027 other papers